Heading 1

Snowmass Retina & Eye 2020 Agenda

​

Retina Subspecialty Symposium

​

CRVO: Top Lessons Learned from SCORE2 and LEAVO, Donald Gass Lecture by Michael Ip, MD 

​

Nonneovascular AMD with Fluid: Mechanisms of Fluid Accumulation in "Dry" AMD, Edward Norton Lecture by David Sarraf, MD

​

The AMD Spectrum—Spaide (this was the Doyne Medal lecture at Oxford this summer)

​

Retinal Vascular Disease Panel

​

AMD Panel

Spaide

             Imaging the Choriocapillaris with OCT Angiography

             Choroidal Imaging in Uveitis
             MacTel2
             Short talks: Biomarkers in AMD,  Anti-VEGF Dosing

Ip

             Utility of Ultra Widefield Imaging 

             Treatment of NPDR: Is it Time Yet?

             Diabetic Retinopathy Severity Staging - Is It Time To Develop A New                                                           Classification Scheme?

Jampol

             What's new from the DRCR Retina Network- DME

             What's new from the DRCR Retina Network--PDR

             Classification of Diabetic Retinopathy for Clinicians and Clinical Trials

Sarraf

              Pentosan Maculopathy: Incidence, Screening Guidelines and Spectrum of Findings

              Pathoanatomical Considerations of the Muller Cell Cone: Insights with Cross Sectional and                    En Face OCT

              A New Biomarker of Ischemia In CRVO and Understanding the Arrangement of                                        the Retinal Capillary Plexus

Stewart

              Iodine and Ophthalmology: How to Handle Patients with “Allergies”

             Oral Therapy for Neovascular Age-Related Macular Degeneration: Is This                                                 Possible?

             Very Frequent Treatment of Chorioretinal Vascular Diseases: Does This work?

Leng 

             The Genetics of AMD

​

Frenkel

             Anti-VEGF Drug Serum Levels & VEGF Levels

​

Ferrara

             Artificial Intelligence In Clinical Research On Retinal Diseases.

Ryan

            TBD  

​

Owens and Shuren

​

             Private Equity in Retina & Ophthalmology

​

​

​

​

Cataract Refractive Subspecialty Symposium

​

Antimicrobial Prophylaxis in Cataract Surgery: Mission Impossible?    Charles Kelman Lecture by Terrence O’Brien, MD

Optimizing Outcomes In Cataract Surgery: Co-morbidities, Challenges & Controversies.   Sir Harold Ridley lecture by Kendall Donaldson, MD 

O’Brien, Donaldson

Detecting Ocular Surface Diseases and Optimization Prior To Cataract Surgery for Optimal Outcomes

Femto-Fever: Fleeting Delirium or Permanent Paradigm Shift in Cataract Surgery?

Femto Pearls and Pitfalls

Complex Astigmatism Cases & Their Management

Preventing Multifocal IOL problems
   
Managing the Dissatisfied Premium Patient

Preventing CME

​

Legal Aspects of Premium Cataract Surgery Co-Management—Owens & Shuren

​

​

​

Glaucoma/MIGS Subspecialty Symposium & Wet Lab - Cantor, Frenkel, Stamper, Vold

​

Paradigm Changes in the Management of Glaucoma—David Epstein Lecture by Steven Vold, MD

​

MIGS: Where Are We Now? Vold

​

Patient Selection for MIGS, LIGS, & Other Glaucoma Procedures—Cantor

​

New Medications In Glaucoma – A Real World Experience-- Stamper

​

Anti-VEGF Drugs & IOP—Frenkel

​

New Information on Laser Trabeculoplasty & Laser Iridotomy (15 min)—Stamper

​

OCT Interpretation in Glaucoma—Cantor

​

Challenging Conventional Thinking on Refractive Corneal and Lens Based Surgery in the Glaucoma Patient—Vold

​

MIGS Wetlab

​

​

​

** Program Subject To Change**

​

​